BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Prosight Management, LP's Holding History (CIK: 0001617201)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 398,700 Value ($000) $2,464 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 1,400,000 Value ($000) $7,112 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 2,232,242 Value ($000) $13,371 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 2,408,135 Value ($000) $17,050 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 2,500,000 Value ($000) $17,600 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 1,074,593 Value ($000) $8,962 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 116,732 Value ($000) $1,340 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 113,800 Value ($000) $1,434 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 176,680 Value ($000) $1,869 Avg Close $10.32 Range $7.61 - $18.00